CD7 drives chemoresistance in acute myeloid leukemia via cytokine-dependent NF-κB signaling
Aberrant expression of the lymphoid antigen CD7 is observed in acute myeloid leukemia (AML) and correlates with adverse clinical outcomes. However, its biological role and mechanistic contribution to treatment failure remain unclear. Here, we systematically characterized CD7 expression across AML subtypes and dif...